5-(4,5,7a,7b-tetramethyl-2,3,3a,5,6,7-hexahydro-1aH-naphtho[1,2-b]oxiren-4-yl)-3-methylpent-2-enal

Details

Top
Internal ID 0326c04a-74cc-4621-8301-3e12053265b8
Taxonomy Organoheterocyclic compounds > Oxepanes
IUPAC Name 5-(4,5,7a,7b-tetramethyl-2,3,3a,5,6,7-hexahydro-1aH-naphtho[1,2-b]oxiren-4-yl)-3-methylpent-2-enal
SMILES (Canonical) CC1CCC2(C(C1(C)CCC(=CC=O)C)CCC3C2(O3)C)C
SMILES (Isomeric) CC1CCC2(C(C1(C)CCC(=CC=O)C)CCC3C2(O3)C)C
InChI InChI=1S/C20H32O2/c1-14(10-13-21)8-11-18(3)15(2)9-12-19(4)16(18)6-7-17-20(19,5)22-17/h10,13,15-17H,6-9,11-12H2,1-5H3
InChI Key LSNASGQUVFPPLR-UHFFFAOYSA-N
Popularity 0 references in papers

Physical and Chemical Properties

Top
Molecular Formula C20H32O2
Molecular Weight 304.50 g/mol
Exact Mass 304.240230259 g/mol
Topological Polar Surface Area (TPSA) 29.60 Ų
XlogP 5.10
Atomic LogP (AlogP) 4.92
H-Bond Acceptor 2
H-Bond Donor 0
Rotatable Bonds 4

Synonyms

Top
There are no found synonyms.

2D Structure

Top
2D Structure of 5-(4,5,7a,7b-tetramethyl-2,3,3a,5,6,7-hexahydro-1aH-naphtho[1,2-b]oxiren-4-yl)-3-methylpent-2-enal

3D Structure

Top

ADMET Properties (via admetSAR 2)

Top
Target Value Probability (raw) Probability (%)
Human Intestinal Absorption + 0.9965 99.65%
Caco-2 + 0.7569 75.69%
Blood Brain Barrier + 0.9250 92.50%
Human oral bioavailability - 0.5429 54.29%
Subcellular localzation Plasma membrane 0.3678 36.78%
OATP2B1 inhibitior - 0.8610 86.10%
OATP1B1 inhibitior + 0.8262 82.62%
OATP1B3 inhibitior + 0.9549 95.49%
MATE1 inhibitior - 0.8400 84.00%
OCT2 inhibitior - 0.6750 67.50%
BSEP inhibitior - 0.6413 64.13%
P-glycoprotein inhibitior - 0.5793 57.93%
P-glycoprotein substrate - 0.7586 75.86%
CYP3A4 substrate + 0.6237 62.37%
CYP2C9 substrate - 1.0000 100.00%
CYP2D6 substrate - 0.8679 86.79%
CYP3A4 inhibition - 0.7356 73.56%
CYP2C9 inhibition - 0.6637 66.37%
CYP2C19 inhibition - 0.5199 51.99%
CYP2D6 inhibition - 0.9401 94.01%
CYP1A2 inhibition + 0.6024 60.24%
CYP2C8 inhibition - 0.6508 65.08%
CYP inhibitory promiscuity - 0.5981 59.81%
UGT catelyzed - 0.0000 0.00%
Carcinogenicity (binary) - 0.8100 81.00%
Carcinogenicity (trinary) Non-required 0.6241 62.41%
Eye corrosion - 0.9810 98.10%
Eye irritation - 0.9628 96.28%
Skin irritation - 0.5728 57.28%
Skin corrosion - 0.9616 96.16%
Ames mutagenesis - 0.6800 68.00%
Human Ether-a-go-go-Related Gene inhibition + 0.7428 74.28%
Micronuclear - 0.7500 75.00%
Hepatotoxicity + 0.5058 50.58%
skin sensitisation + 0.6331 63.31%
Respiratory toxicity - 0.5889 58.89%
Reproductive toxicity + 0.5889 58.89%
Mitochondrial toxicity + 0.5125 51.25%
Nephrotoxicity - 0.6438 64.38%
Acute Oral Toxicity (c) III 0.7460 74.60%
Estrogen receptor binding + 0.8965 89.65%
Androgen receptor binding + 0.6030 60.30%
Thyroid receptor binding + 0.6754 67.54%
Glucocorticoid receptor binding + 0.6285 62.85%
Aromatase binding + 0.6590 65.90%
PPAR gamma - 0.5000 50.00%
Honey bee toxicity - 0.7997 79.97%
Biodegradation - 0.8500 85.00%
Crustacea aquatic toxicity - 0.5500 55.00%
Fish aquatic toxicity + 0.9816 98.16%

Targets

Top

Proven Targets:

CHEMBL ID UniProt ID Name Min activity Assay type Source
No proven targets yet!

Predicted Targets (via Super-PRED):

CHEMBL ID UniProt ID Name Probability Model accuracy
CHEMBL5619 P27695 DNA-(apurinic or apyrimidinic site) lyase 94.70% 91.11%
CHEMBL3251 P19838 Nuclear factor NF-kappa-B p105 subunit 93.58% 96.09%
CHEMBL253 P34972 Cannabinoid CB2 receptor 92.47% 97.25%
CHEMBL218 P21554 Cannabinoid CB1 receptor 89.21% 96.61%
CHEMBL4187 Q99250 Sodium channel protein type II alpha subunit 86.20% 95.50%
CHEMBL3108638 O15164 Transcription intermediary factor 1-alpha 86.13% 95.56%
CHEMBL233 P35372 Mu opioid receptor 85.38% 97.93%
CHEMBL2140 P48775 Tryptophan 2,3-dioxygenase 83.23% 98.46%
CHEMBL1994 P08235 Mineralocorticoid receptor 81.11% 100.00%

Plants that contains it

Top
Below are displayed all the plants proven (via scientific papers) to contain this compound!
To see more specific details click the taxa you are interested in.
Solidago gigantea

Cross-Links

Top
PubChem 163083769
LOTUS LTS0069815
wikiData Q105156655